BlackRock Inc. - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACK and the CUSIP is 590328209. A total of 43 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 2.37 and the average weighting 0.3%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$8,517,775
+2.4%
690,817
+2.1%
0.00%
Q2 2023$8,318,367
+204.5%
676,290
+204.3%
0.00%
Q1 2023$2,731,490
+13.6%
222,253
+6.0%
0.00%
Q4 2022$2,403,827
+210.2%
209,758
+1.4%
0.00%
Q3 2022$775,000
-37.2%
206,783
-0.4%
0.00%
Q2 2022$1,235,000
-7.7%
207,715
-1.8%
0.00%
Q1 2022$1,338,000
+60.8%
211,439
-0.6%
0.00%
Q4 2021$832,000
-18.4%
212,663
+0.8%
0.00%
Q3 2021$1,020,000
-14.6%
211,051
+12.8%
0.00%
Q2 2021$1,195,000
-25.5%
187,090
-26.8%
0.00%
Q1 2021$1,605,000
-7.5%
255,503
+1.4%
0.00%
Q4 2020$1,736,000
+71.5%
251,931
-0.3%
0.00%
Q3 2020$1,012,000
+21.1%
252,780
+0.7%
0.00%
Q2 2020$836,000
+56.8%
250,934
+1.2%
0.00%
Q1 2020$533,000
-31.9%
247,922
-0.3%
0.00%
Q4 2019$783,000
-30.1%
248,693
-0.1%
0.00%
Q3 2019$1,120,000
-26.1%
248,862
-0.7%
0.00%
Q2 2019$1,515,000
-14.5%
250,491
-1.7%
0.00%
Q1 2019$1,771,000
+79.1%
254,831
-0.5%
0.00%
Q4 2018$989,000
-27.0%
256,175
+0.8%
0.00%
Q3 2018$1,355,000
+9.3%
254,218
+0.6%
0.00%
Q2 2018$1,240,000
-80.9%
252,594
-68.6%
0.00%
Q1 2018$6,482,000
-22.2%
805,320
-0.9%
0.00%
Q4 2017$8,333,000
-44.6%
813,041
-21.4%
0.00%
-100.0%
Q3 2017$15,036,0001,033,9960.00%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q2 2022
NameSharesValueWeighting ↓
Western Standard LLC 1,894,013$23,353,18021.09%
Newtyn Management, LLC 1,873,694$23,102,6475.70%
Sio Capital Management, LLC 288,466$3,556,7861.10%
Madison Avenue Partners, LP 553,085$6,819,5380.97%
WITTENBERG INVESTMENT MANAGEMENT, INC. 209,739$2,5860.95%
Indaba Capital Management, L.P. 136,802$1,686,7690.50%
Sepio Capital, LP 306,680$3,781,3640.33%
Yakira Capital Management, Inc. 54,118$667,2750.18%
Centiva Capital, LP 187,803$2,315,6110.05%
FIFTH LANE CAPITAL, LP 10,929$134,4270.05%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders